METTL3 and systemic lupus erythematosus: Pharmacological inhibition of METTL3 in our cGVHD model significantly aggravated the lupus-like phenotype, as indicated by higher levels of autoantibodies in the serum, more severe kidney damage, and more accumulation of immune complexes in the glomerulus.